English
简体中文
Total: £ 56.28
Published Date: 2025-09-18 | Pages: 111 | Tables: 115 | Pharma & Healthcare
The global Parenteral Nutrition market size was US$ 4327 million in 2024 and is forecast to a readjusted size of US$ 6060 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Parenteral Nutrition market competitiveness, regional economic performance, and supply chain configurations.
Parenteral nutrition, also known as total parenteral nutrition, refers to the use of intravenous infusion to supplement the nutritional drugs necessary for the human body without absorption through the intestines, including amino acids, carbohydrates, fat emulsions, vitamins and trace elements.
Among the units in this report, 1 unit represents 1 bottle or 1 bag of parenteral nutrition product.
In addition, pure glucose and pure sodium chloride products, as well as mixed multi-bag products of glucose and sodium chloride, are not included in this report.
As a supplement to enteral nutrition, parenteral nutrition has experienced rapid development in the early 21st century, but the industry growth rate has slowed down in recent years. However, compared with developed countries, there is still a lot of room for growth in parenteral nutrition supplementation in China. According to Fresenius's 2021 market assessment and report, the average annual growth rate in the Asia-Pacific region will remain at around 5% in 2021.
Global key players of Parenteral Nutrition include Fresenius Kabi, Baxter, B. Braun, Kelun Pharma, JW Pharmaceutical, etc. The top five players hold a share about 51%. Asia-Pacific is the largest market, and has a share about 38%, followed by Europe and North America with share 29% and 27%, separately. In terms of product type, Heat and Fat Emulsion is the largest segment, accounting for a share of 64%. In terms of application, One-Chamber is the largest field with a share about 72 percent.
The global Parenteral Nutrition market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Baxter
B. Braun
Fresenius Kabi
Kelun Pharma
Otsuka Pharmaceutical
JW Pharmaceutical
Grifols
Haisco Pharmaceutical Group
King York
Cisen
BBCA Pharmaceutical
Biokin Pharmaceutical
Xi'an Libang Pharmaceutical
Lionco Pharmaceutical
Grand Life Sciences
Lummy
BBCA Pharmaceutical
China Meheco Kangli
Weixinkang
Baizheng Pharmaceutical
Aguettant
By Type: (Dominant Segment vs High-Margin Innovation)
Heat and Fat Emulsion
Amino Acid
Alanyl-Glutamine
Vitamins
Trace Elements
By Application: (Core Demand Driver vs Emerging Opportunity)
One-Chamber
Two-Chamber
Three-Chamber
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Baxter in Europe)
- Emerging Product Trends: Heat and Fat Emulsion adoption vs. Amino Acid premiumization
- Demand-Side Dynamics: One-Chamber growth in China vs. Two-Chamber potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
India
South Korea
Brazil
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Parenteral Nutrition market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Amino Acid in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Two-Chamber in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Heat and Fat Emulsion dominance in Europe vs. Amino Acid demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Parenteral Nutrition Product Scope
1.2 Parenteral Nutrition by Type
1.2.1 Global Parenteral Nutrition Sales by Type (2020 & 2024 & 2031)
1.2.2 Heat and Fat Emulsion
1.2.3 Amino Acid
1.2.4 Alanyl-Glutamine
1.2.5 Vitamins
1.2.6 Trace Elements
1.3 Parenteral Nutrition by Application
1.3.1 Global Parenteral Nutrition Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 One-Chamber
1.3.3 Two-Chamber
1.3.4 Three-Chamber
1.4 Global Parenteral Nutrition Market Estimates and Forecasts (2020-2031)
1.4.1 Global Parenteral Nutrition Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Parenteral Nutrition Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Parenteral Nutrition Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Parenteral Nutrition Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Parenteral Nutrition Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Parenteral Nutrition Sales Market Share by Region (2020-2025)
2.2.2 Global Parenteral Nutrition Revenue Market Share by Region (2020-2025)
2.3 Global Parenteral Nutrition Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Parenteral Nutrition Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Parenteral Nutrition Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Parenteral Nutrition Market Size and Prospective (2020-2031)
2.4.2 Europe Parenteral Nutrition Market Size and Prospective (2020-2031)
2.4.3 China Parenteral Nutrition Market Size and Prospective (2020-2031)
2.4.4 Japan Parenteral Nutrition Market Size and Prospective (2020-2031)
2.4.5 India Parenteral Nutrition Market Size and Prospective (2020-2031)
2.4.6 South Korea Parenteral Nutrition Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Parenteral Nutrition Historic Market Review by Type (2020-2025)
3.1.1 Global Parenteral Nutrition Sales by Type (2020-2025)
3.1.2 Global Parenteral Nutrition Revenue by Type (2020-2025)
3.1.3 Global Parenteral Nutrition Price by Type (2020-2025)
3.2 Global Parenteral Nutrition Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Parenteral Nutrition Sales Forecast by Type (2026-2031)
3.2.2 Global Parenteral Nutrition Revenue Forecast by Type (2026-2031)
3.2.3 Global Parenteral Nutrition Price Forecast by Type (2026-2031)
3.3 Different Types Parenteral Nutrition Representative Players
4 Global Market Size by Application
4.1 Global Parenteral Nutrition Historic Market Review by Application (2020-2025)
4.1.1 Global Parenteral Nutrition Sales by Application (2020-2025)
4.1.2 Global Parenteral Nutrition Revenue by Application (2020-2025)
4.1.3 Global Parenteral Nutrition Price by Application (2020-2025)
4.2 Global Parenteral Nutrition Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Parenteral Nutrition Sales Forecast by Application (2026-2031)
4.2.2 Global Parenteral Nutrition Revenue Forecast by Application (2026-2031)
4.2.3 Global Parenteral Nutrition Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Parenteral Nutrition Application
5 Competition Landscape by Players
5.1 Global Parenteral Nutrition Sales by Players (2020-2025)
5.2 Global Top Parenteral Nutrition Players by Revenue (2020-2025)
5.3 Global Parenteral Nutrition Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parenteral Nutrition as of 2024)
5.4 Global Parenteral Nutrition Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Parenteral Nutrition, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Parenteral Nutrition, Product Type & Application
5.7 Global Key Manufacturers of Parenteral Nutrition, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Parenteral Nutrition Sales by Company
6.1.1.1 North America Parenteral Nutrition Sales by Company (2020-2025)
6.1.1.2 North America Parenteral Nutrition Revenue by Company (2020-2025)
6.1.2 North America Parenteral Nutrition Sales Breakdown by Type (2020-2025)
6.1.3 North America Parenteral Nutrition Sales Breakdown by Application (2020-2025)
6.1.4 North America Parenteral Nutrition Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Parenteral Nutrition Sales by Company
6.2.1.1 Europe Parenteral Nutrition Sales by Company (2020-2025)
6.2.1.2 Europe Parenteral Nutrition Revenue by Company (2020-2025)
6.2.2 Europe Parenteral Nutrition Sales Breakdown by Type (2020-2025)
6.2.3 Europe Parenteral Nutrition Sales Breakdown by Application (2020-2025)
6.2.4 Europe Parenteral Nutrition Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Parenteral Nutrition Sales by Company
6.3.1.1 China Parenteral Nutrition Sales by Company (2020-2025)
6.3.1.2 China Parenteral Nutrition Revenue by Company (2020-2025)
6.3.2 China Parenteral Nutrition Sales Breakdown by Type (2020-2025)
6.3.3 China Parenteral Nutrition Sales Breakdown by Application (2020-2025)
6.3.4 China Parenteral Nutrition Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Parenteral Nutrition Sales by Company
6.4.1.1 Japan Parenteral Nutrition Sales by Company (2020-2025)
6.4.1.2 Japan Parenteral Nutrition Revenue by Company (2020-2025)
6.4.2 Japan Parenteral Nutrition Sales Breakdown by Type (2020-2025)
6.4.3 Japan Parenteral Nutrition Sales Breakdown by Application (2020-2025)
6.4.4 Japan Parenteral Nutrition Major Customer
6.4.5 Japan Market Trend and Opportunities
6.5 India Market: Players, Segments, Downstream and Major Customers
6.5.1 India Parenteral Nutrition Sales by Company
6.5.1.1 India Parenteral Nutrition Sales by Company (2020-2025)
6.5.1.2 India Parenteral Nutrition Revenue by Company (2020-2025)
6.5.2 India Parenteral Nutrition Sales Breakdown by Type (2020-2025)
6.5.3 India Parenteral Nutrition Sales Breakdown by Application (2020-2025)
6.5.4 India Parenteral Nutrition Major Customer
6.5.5 India Market Trend and Opportunities
6.6 South Korea Market: Players, Segments, Downstream and Major Customers
6.6.1 South Korea Parenteral Nutrition Sales by Company
6.6.1.1 South Korea Parenteral Nutrition Sales by Company (2020-2025)
6.6.1.2 South Korea Parenteral Nutrition Revenue by Company (2020-2025)
6.6.2 South Korea Parenteral Nutrition Sales Breakdown by Type (2020-2025)
6.6.3 South Korea Parenteral Nutrition Sales Breakdown by Application (2020-2025)
6.6.4 South Korea Parenteral Nutrition Major Customer
6.6.5 South Korea Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Baxter
7.1.1 Baxter Company Information
7.1.2 Baxter Business Overview
7.1.3 Baxter Parenteral Nutrition Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Baxter Parenteral Nutrition Products Offered
7.1.5 Baxter Recent Development
7.2 B. Braun
7.2.1 B. Braun Company Information
7.2.2 B. Braun Business Overview
7.2.3 B. Braun Parenteral Nutrition Sales, Revenue and Gross Margin (2020-2025)
7.2.4 B. Braun Parenteral Nutrition Products Offered
7.2.5 B. Braun Recent Development
7.3 Fresenius Kabi
7.3.1 Fresenius Kabi Company Information
7.3.2 Fresenius Kabi Business Overview
7.3.3 Fresenius Kabi Parenteral Nutrition Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Fresenius Kabi Parenteral Nutrition Products Offered
7.3.5 Fresenius Kabi Recent Development
7.4 Kelun Pharma
7.4.1 Kelun Pharma Company Information
7.4.2 Kelun Pharma Business Overview
7.4.3 Kelun Pharma Parenteral Nutrition Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Kelun Pharma Parenteral Nutrition Products Offered
7.4.5 Kelun Pharma Recent Development
7.5 Otsuka Pharmaceutical
7.5.1 Otsuka Pharmaceutical Company Information
7.5.2 Otsuka Pharmaceutical Business Overview
7.5.3 Otsuka Pharmaceutical Parenteral Nutrition Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Otsuka Pharmaceutical Parenteral Nutrition Products Offered
7.5.5 Otsuka Pharmaceutical Recent Development
7.6 JW Pharmaceutical
7.6.1 JW Pharmaceutical Company Information
7.6.2 JW Pharmaceutical Business Overview
7.6.3 JW Pharmaceutical Parenteral Nutrition Sales, Revenue and Gross Margin (2020-2025)
7.6.4 JW Pharmaceutical Parenteral Nutrition Products Offered
7.6.5 JW Pharmaceutical Recent Development
7.7 Grifols
7.7.1 Grifols Company Information
7.7.2 Grifols Business Overview
7.7.3 Grifols Parenteral Nutrition Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Grifols Parenteral Nutrition Products Offered
7.7.5 Grifols Recent Development
7.8 Haisco Pharmaceutical Group
7.8.1 Haisco Pharmaceutical Group Company Information
7.8.2 Haisco Pharmaceutical Group Business Overview
7.8.3 Haisco Pharmaceutical Group Parenteral Nutrition Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Haisco Pharmaceutical Group Parenteral Nutrition Products Offered
7.8.5 Haisco Pharmaceutical Group Recent Development
7.9 King York
7.9.1 King York Company Information
7.9.2 King York Business Overview
7.9.3 King York Parenteral Nutrition Sales, Revenue and Gross Margin (2020-2025)
7.9.4 King York Parenteral Nutrition Products Offered
7.9.5 King York Recent Development
7.10 Cisen
7.10.1 Cisen Company Information
7.10.2 Cisen Business Overview
7.10.3 Cisen Parenteral Nutrition Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Cisen Parenteral Nutrition Products Offered
7.10.5 Cisen Recent Development
7.11 BBCA Pharmaceutical
7.11.1 BBCA Pharmaceutical Company Information
7.11.2 BBCA Pharmaceutical Business Overview
7.11.3 BBCA Pharmaceutical Parenteral Nutrition Sales, Revenue and Gross Margin (2020-2025)
7.11.4 BBCA Pharmaceutical Parenteral Nutrition Products Offered
7.11.5 BBCA Pharmaceutical Recent Development
7.12 Biokin Pharmaceutical
7.12.1 Biokin Pharmaceutical Company Information
7.12.2 Biokin Pharmaceutical Business Overview
7.12.3 Biokin Pharmaceutical Parenteral Nutrition Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Biokin Pharmaceutical Parenteral Nutrition Products Offered
7.12.5 Biokin Pharmaceutical Recent Development
7.13 Xi'an Libang Pharmaceutical
7.13.1 Xi'an Libang Pharmaceutical Company Information
7.13.2 Xi'an Libang Pharmaceutical Business Overview
7.13.3 Xi'an Libang Pharmaceutical Parenteral Nutrition Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Xi'an Libang Pharmaceutical Parenteral Nutrition Products Offered
7.13.5 Xi'an Libang Pharmaceutical Recent Development
7.14 Lionco Pharmaceutical
7.14.1 Lionco Pharmaceutical Company Information
7.14.2 Lionco Pharmaceutical Business Overview
7.14.3 Lionco Pharmaceutical Parenteral Nutrition Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Lionco Pharmaceutical Parenteral Nutrition Products Offered
7.14.5 Lionco Pharmaceutical Recent Development
7.15 Grand Life Sciences
7.15.1 Grand Life Sciences Company Information
7.15.2 Grand Life Sciences Business Overview
7.15.3 Grand Life Sciences Parenteral Nutrition Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Grand Life Sciences Parenteral Nutrition Products Offered
7.15.5 Grand Life Sciences Recent Development
7.16 Lummy
7.16.1 Lummy Company Information
7.16.2 Lummy Business Overview
7.16.3 Lummy Parenteral Nutrition Sales, Revenue and Gross Margin (2020-2025)
7.16.4 Lummy Parenteral Nutrition Products Offered
7.16.5 Lummy Recent Development
7.17 BBCA Pharmaceutical
7.17.1 BBCA Pharmaceutical Company Information
7.17.2 BBCA Pharmaceutical Business Overview
7.17.3 BBCA Pharmaceutical Parenteral Nutrition Sales, Revenue and Gross Margin (2020-2025)
7.17.4 BBCA Pharmaceutical Parenteral Nutrition Products Offered
7.17.5 BBCA Pharmaceutical Recent Development
7.18 China Meheco Kangli
7.18.1 China Meheco Kangli Company Information
7.18.2 China Meheco Kangli Business Overview
7.18.3 China Meheco Kangli Parenteral Nutrition Sales, Revenue and Gross Margin (2020-2025)
7.18.4 China Meheco Kangli Parenteral Nutrition Products Offered
7.18.5 China Meheco Kangli Recent Development
7.19 Weixinkang
7.19.1 Weixinkang Company Information
7.19.2 Weixinkang Business Overview
7.19.3 Weixinkang Parenteral Nutrition Sales, Revenue and Gross Margin (2020-2025)
7.19.4 Weixinkang Parenteral Nutrition Products Offered
7.19.5 Weixinkang Recent Development
7.20 Baizheng Pharmaceutical
7.20.1 Baizheng Pharmaceutical Company Information
7.20.2 Baizheng Pharmaceutical Business Overview
7.20.3 Baizheng Pharmaceutical Parenteral Nutrition Sales, Revenue and Gross Margin (2020-2025)
7.20.4 Baizheng Pharmaceutical Parenteral Nutrition Products Offered
7.20.5 Baizheng Pharmaceutical Recent Development
7.21 Aguettant
7.21.1 Aguettant Company Information
7.21.2 Aguettant Business Overview
7.21.3 Aguettant Parenteral Nutrition Sales, Revenue and Gross Margin (2020-2025)
7.21.4 Aguettant Parenteral Nutrition Products Offered
7.21.5 Aguettant Recent Development
8 Parenteral Nutrition Manufacturing Cost Analysis
8.1 Parenteral Nutrition Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Parenteral Nutrition
8.4 Parenteral Nutrition Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Parenteral Nutrition Distributors List
9.3 Parenteral Nutrition Customers
10 Parenteral Nutrition Market Dynamics
10.1 Parenteral Nutrition Industry Trends
10.2 Parenteral Nutrition Market Drivers
10.3 Parenteral Nutrition Market Challenges
10.4 Parenteral Nutrition Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Parenteral Nutrition Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Parenteral Nutrition Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Parenteral Nutrition Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Parenteral Nutrition Sales (M Units) by Region (2020-2025)
Table 5. Global Parenteral Nutrition Sales Market Share by Region (2020-2025)
Table 6. Global Parenteral Nutrition Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Parenteral Nutrition Revenue Share by Region (2020-2025)
Table 8. Global Parenteral Nutrition Sales (M Units) Forecast by Region (2026-2031)
Table 9. Global Parenteral Nutrition Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Parenteral Nutrition Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Parenteral Nutrition Revenue Share Forecast by Region (2026-2031)
Table 12. Global Parenteral Nutrition Sales by Type (M Units) & (2020-2025)
Table 13. Global Parenteral Nutrition Sales Share by Type (2020-2025)
Table 14. Global Parenteral Nutrition Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Parenteral Nutrition Price by Type (US$/Unit) & (2020-2025)
Table 16. Global Parenteral Nutrition Sales by Type (M Units) & (2026-2031)
Table 17. Global Parenteral Nutrition Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Parenteral Nutrition Price by Type (US$/Unit) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Parenteral Nutrition Sales by Application (M Units) & (2020-2025)
Table 21. Global Parenteral Nutrition Sales Share by Application (2020-2025)
Table 22. Global Parenteral Nutrition Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Parenteral Nutrition Price by Application (US$/Unit) & (2020-2025)
Table 24. Global Parenteral Nutrition Sales by Application (M Units) & (2026-2031)
Table 25. Global Parenteral Nutrition Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Parenteral Nutrition Price by Application (US$/Unit) & (2026-2031)
Table 27. New Sources of Growth in Parenteral Nutrition Application
Table 28. Global Parenteral Nutrition Sales by Company (M Units) & (2020-2025)
Table 29. Global Parenteral Nutrition Sales Share by Company (2020-2025)
Table 30. Global Parenteral Nutrition Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Parenteral Nutrition Revenue Share by Company (2020-2025)
Table 32. Global Parenteral Nutrition by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parenteral Nutrition as of 2024)
Table 33. Global Market Parenteral Nutrition Average Price by Company (US$/Unit) & (2020-2025)
Table 34. Global Key Manufacturers of Parenteral Nutrition, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Parenteral Nutrition, Product Type & Application
Table 36. Global Key Manufacturers of Parenteral Nutrition, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Parenteral Nutrition Sales by Company (2020-2025) & (M Units)
Table 39. North America Parenteral Nutrition Sales Market Share by Company (2020-2025)
Table 40. North America Parenteral Nutrition Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Parenteral Nutrition Revenue Market Share by Company (2020-2025)
Table 42. North America Parenteral Nutrition Sales by Type (2020-2025) & (M Units)
Table 43. North America Parenteral Nutrition Sales Market Share by Type (2020-2025)
Table 44. North America Parenteral Nutrition Sales by Application (2020-2025) & (M Units)
Table 45. North America Parenteral Nutrition Sales Market Share by Application (2020-2025)
Table 46. Europe Parenteral Nutrition Sales by Company (2020-2025) & (M Units)
Table 47. Europe Parenteral Nutrition Sales Market Share by Company (2020-2025)
Table 48. Europe Parenteral Nutrition Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Parenteral Nutrition Revenue Market Share by Company (2020-2025)
Table 50. Europe Parenteral Nutrition Sales by Type (2020-2025) & (M Units)
Table 51. Europe Parenteral Nutrition Sales Market Share by Type (2020-2025)
Table 52. Europe Parenteral Nutrition Sales by Application (2020-2025) & (M Units)
Table 53. Europe Parenteral Nutrition Sales Market Share by Application (2020-2025)
Table 54. China Parenteral Nutrition Sales by Company (2020-2025) & (M Units)
Table 55. China Parenteral Nutrition Sales Market Share by Company (2020-2025)
Table 56. China Parenteral Nutrition Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Parenteral Nutrition Revenue Market Share by Company (2020-2025)
Table 58. China Parenteral Nutrition Sales by Type (2020-2025) & (M Units)
Table 59. China Parenteral Nutrition Sales Market Share by Type (2020-2025)
Table 60. China Parenteral Nutrition Sales by Application (2020-2025) & (M Units)
Table 61. China Parenteral Nutrition Sales Market Share by Application (2020-2025)
Table 62. Japan Parenteral Nutrition Sales by Company (2020-2025) & (M Units)
Table 63. Japan Parenteral Nutrition Sales Market Share by Company (2020-2025)
Table 64. Japan Parenteral Nutrition Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Parenteral Nutrition Revenue Market Share by Company (2020-2025)
Table 66. Japan Parenteral Nutrition Sales by Type (2020-2025) & (M Units)
Table 67. Japan Parenteral Nutrition Sales Market Share by Type (2020-2025)
Table 68. Japan Parenteral Nutrition Sales by Application (2020-2025) & (M Units)
Table 69. Japan Parenteral Nutrition Sales Market Share by Application (2020-2025)
Table 70. India Parenteral Nutrition Sales by Company (2020-2025) & (M Units)
Table 71. India Parenteral Nutrition Sales Market Share by Company (2020-2025)
Table 72. India Parenteral Nutrition Revenue by Company (2020-2025) & (US$ Million)
Table 73. India Parenteral Nutrition Revenue Market Share by Company (2020-2025)
Table 74. India Parenteral Nutrition Sales by Type (2020-2025) & (M Units)
Table 75. India Parenteral Nutrition Sales Market Share by Type (2020-2025)
Table 76. India Parenteral Nutrition Sales by Application (2020-2025) & (M Units)
Table 77. India Parenteral Nutrition Sales Market Share by Application (2020-2025)
Table 78. South Korea Parenteral Nutrition Sales by Company (2020-2025) & (M Units)
Table 79. South Korea Parenteral Nutrition Sales Market Share by Company (2020-2025)
Table 80. South Korea Parenteral Nutrition Revenue by Company (2020-2025) & (US$ Million)
Table 81. South Korea Parenteral Nutrition Revenue Market Share by Company (2020-2025)
Table 82. South Korea Parenteral Nutrition Sales by Type (2020-2025) & (M Units)
Table 83. South Korea Parenteral Nutrition Sales Market Share by Type (2020-2025)
Table 84. South Korea Parenteral Nutrition Sales by Application (2020-2025) & (M Units)
Table 85. South Korea Parenteral Nutrition Sales Market Share by Application (2020-2025)
Table 86. Baxter Company Information
Table 87. Baxter Description and Business Overview
Table 88. Baxter Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 89. Baxter Parenteral Nutrition Product
Table 90. Baxter Recent Development
Table 91. B. Braun Company Information
Table 92. B. Braun Description and Business Overview
Table 93. B. Braun Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 94. B. Braun Parenteral Nutrition Product
Table 95. B. Braun Recent Development
Table 96. Fresenius Kabi Company Information
Table 97. Fresenius Kabi Description and Business Overview
Table 98. Fresenius Kabi Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Fresenius Kabi Parenteral Nutrition Product
Table 100. Fresenius Kabi Recent Development
Table 101. Kelun Pharma Company Information
Table 102. Kelun Pharma Description and Business Overview
Table 103. Kelun Pharma Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Kelun Pharma Parenteral Nutrition Product
Table 105. Kelun Pharma Recent Development
Table 106. Otsuka Pharmaceutical Company Information
Table 107. Otsuka Pharmaceutical Description and Business Overview
Table 108. Otsuka Pharmaceutical Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Otsuka Pharmaceutical Parenteral Nutrition Product
Table 110. Otsuka Pharmaceutical Recent Development
Table 111. JW Pharmaceutical Company Information
Table 112. JW Pharmaceutical Description and Business Overview
Table 113. JW Pharmaceutical Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. JW Pharmaceutical Parenteral Nutrition Product
Table 115. JW Pharmaceutical Recent Development
Table 116. Grifols Company Information
Table 117. Grifols Description and Business Overview
Table 118. Grifols Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Grifols Parenteral Nutrition Product
Table 120. Grifols Recent Development
Table 121. Haisco Pharmaceutical Group Company Information
Table 122. Haisco Pharmaceutical Group Description and Business Overview
Table 123. Haisco Pharmaceutical Group Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Haisco Pharmaceutical Group Parenteral Nutrition Product
Table 125. Haisco Pharmaceutical Group Recent Development
Table 126. King York Company Information
Table 127. King York Description and Business Overview
Table 128. King York Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. King York Parenteral Nutrition Product
Table 130. King York Recent Development
Table 131. Cisen Company Information
Table 132. Cisen Description and Business Overview
Table 133. Cisen Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Cisen Parenteral Nutrition Product
Table 135. Cisen Recent Development
Table 136. BBCA Pharmaceutical Company Information
Table 137. BBCA Pharmaceutical Description and Business Overview
Table 138. BBCA Pharmaceutical Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. BBCA Pharmaceutical Parenteral Nutrition Product
Table 140. BBCA Pharmaceutical Recent Development
Table 141. Biokin Pharmaceutical Company Information
Table 142. Biokin Pharmaceutical Description and Business Overview
Table 143. Biokin Pharmaceutical Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Biokin Pharmaceutical Parenteral Nutrition Product
Table 145. Biokin Pharmaceutical Recent Development
Table 146. Xi'an Libang Pharmaceutical Company Information
Table 147. Xi'an Libang Pharmaceutical Description and Business Overview
Table 148. Xi'an Libang Pharmaceutical Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. Xi'an Libang Pharmaceutical Parenteral Nutrition Product
Table 150. Xi'an Libang Pharmaceutical Recent Development
Table 151. Lionco Pharmaceutical Company Information
Table 152. Lionco Pharmaceutical Description and Business Overview
Table 153. Lionco Pharmaceutical Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. Lionco Pharmaceutical Parenteral Nutrition Product
Table 155. Lionco Pharmaceutical Recent Development
Table 156. Grand Life Sciences Company Information
Table 157. Grand Life Sciences Description and Business Overview
Table 158. Grand Life Sciences Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 159. Grand Life Sciences Parenteral Nutrition Product
Table 160. Grand Life Sciences Recent Development
Table 161. Lummy Company Information
Table 162. Lummy Description and Business Overview
Table 163. Lummy Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 164. Lummy Parenteral Nutrition Product
Table 165. Lummy Recent Development
Table 166. BBCA Pharmaceutical Company Information
Table 167. BBCA Pharmaceutical Description and Business Overview
Table 168. BBCA Pharmaceutical Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 169. BBCA Pharmaceutical Parenteral Nutrition Product
Table 170. BBCA Pharmaceutical Recent Development
Table 171. China Meheco Kangli Company Information
Table 172. China Meheco Kangli Description and Business Overview
Table 173. China Meheco Kangli Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 174. China Meheco Kangli Parenteral Nutrition Product
Table 175. China Meheco Kangli Recent Development
Table 176. Weixinkang Company Information
Table 177. Weixinkang Description and Business Overview
Table 178. Weixinkang Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 179. Weixinkang Parenteral Nutrition Product
Table 180. Weixinkang Recent Development
Table 181. Baizheng Pharmaceutical Company Information
Table 182. Baizheng Pharmaceutical Description and Business Overview
Table 183. Baizheng Pharmaceutical Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 184. Baizheng Pharmaceutical Parenteral Nutrition Product
Table 185. Baizheng Pharmaceutical Recent Development
Table 186. Aguettant Company Information
Table 187. Aguettant Description and Business Overview
Table 188. Aguettant Parenteral Nutrition Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 189. Aguettant Parenteral Nutrition Product
Table 190. Aguettant Recent Development
Table 191. Production Base and Market Concentration Rate of Raw Material
Table 192. Key Suppliers of Raw Materials
Table 193. Parenteral Nutrition Distributors List
Table 194. Parenteral Nutrition Customers List
Table 195. Parenteral Nutrition Market Trends
Table 196. Parenteral Nutrition Market Drivers
Table 197. Parenteral Nutrition Market Challenges
Table 198. Parenteral Nutrition Market Restraints
Table 199. Research Programs/Design for This Report
Table 200. Key Data Information from Secondary Sources
Table 201. Key Data Information from Primary Sources
List of Figures
Figure 1. Parenteral Nutrition Product Picture
Figure 2. Global Parenteral Nutrition Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Parenteral Nutrition Sales Market Share by Type in 2024 & 2031
Figure 4. Heat and Fat Emulsion Product Picture
Figure 5. Amino Acid Product Picture
Figure 6. Alanyl-Glutamine Product Picture
Figure 7. Vitamins Product Picture
Figure 8. Trace Elements Product Picture
Figure 9. Global Parenteral Nutrition Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 10. Global Parenteral Nutrition Sales Market Share by Application in 2024 & 2031
Figure 11. One-Chamber Examples
Figure 12. Two-Chamber Examples
Figure 13. Three-Chamber Examples
Figure 14. Global Parenteral Nutrition Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Parenteral Nutrition Sales Growth Rate (2020-2031) & (US$ Million)
Figure 16. Global Parenteral Nutrition Sales (M Units) Growth Rate (2020-2031)
Figure 17. Global Parenteral Nutrition Price Trends Growth Rate (2020-2031) & (US$/Unit)
Figure 18. Parenteral Nutrition Report Years Considered
Figure 19. Global Market Parenteral Nutrition Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 20. Global Parenteral Nutrition Revenue Market Share by Region: 2020 VS 2024
Figure 21. North America Parenteral Nutrition Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. North America Parenteral Nutrition Sales (M Units) Growth Rate (2020-2031)
Figure 23. Europe Parenteral Nutrition Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. Europe Parenteral Nutrition Sales (M Units) Growth Rate (2020-2031)
Figure 25. China Parenteral Nutrition Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. China Parenteral Nutrition Sales (M Units) Growth Rate (2020-2031)
Figure 27. Japan Parenteral Nutrition Revenue (US$ Million) Growth Rate (2020-2031)
Figure 28. Japan Parenteral Nutrition Sales (M Units) Growth Rate (2020-2031)
Figure 29. India Parenteral Nutrition Revenue (US$ Million) Growth Rate (2020-2031)
Figure 30. India Parenteral Nutrition Sales (M Units) Growth Rate (2020-2031)
Figure 31. South Korea Parenteral Nutrition Revenue (US$ Million) Growth Rate (2020-2031)
Figure 32. South Korea Parenteral Nutrition Sales (M Units) Growth Rate (2020-2031)
Figure 33. Global Parenteral Nutrition Revenue Share by Type (2020-2025)
Figure 34. Global Parenteral Nutrition Sales Share by Type (2026-2031)
Figure 35. Global Parenteral Nutrition Revenue Share by Type (2026-2031)
Figure 36. Global Parenteral Nutrition Revenue Share by Application (2020-2025)
Figure 37. Global Parenteral Nutrition Revenue Growth Rate by Application in 2020 & 2024
Figure 38. Global Parenteral Nutrition Sales Share by Application (2026-2031)
Figure 39. Global Parenteral Nutrition Revenue Share by Application (2026-2031)
Figure 40. Global Parenteral Nutrition Sales Share by Company (2024)
Figure 41. Global Parenteral Nutrition Revenue Share by Company (2024)
Figure 42. Global 5 Largest Parenteral Nutrition Players Market Share by Revenue in Parenteral Nutrition: 2020 & 2024
Figure 43. Parenteral Nutrition Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 44. Manufacturing Cost Structure of Parenteral Nutrition
Figure 45. Manufacturing Process Analysis of Parenteral Nutrition
Figure 46. Parenteral Nutrition Industrial Chain
Figure 47. Channels of Distribution (Direct Vs Distribution)
Figure 48. Distributors Profiles
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed
